Qiuyan Chen – Research & Development Scientist

EDUCATION:

Postdoc – University of Pittsburgh

PhD – Peking Union Medical College/Chinese Academy of Medical Sciences: Molecular Immunology

MD – Medical College of Xian Jiaotong University

MS – Medical College of Xian Jiaotong University: Pathology/Tumor Immunology

 

 

Qiuyan Chen, MD, Ph.D., has an exceptional multidisciplinary background in the biosciences from the molecular to the clinical level. She completed her Ph.D. studies in molecular immunology at the Peking Union Medical College/Chinese Academy of Medical Sciences, and a Master’s degree in pathology focusing on tumor immunology at Medical College of Xian Jiaotong University where she also completed her medical degree. After initially practicing medicine, her passion for tumor immunology and problem solving capabilities drove her to dedicate herself to research in immune regulation and cancer biology. Upon completing postdoctoral training at the University of Pittsburgh, she joined the research faculty at Pennsylvania State University where she focused on understanding the role of monocytes during carcinogenesis, T and NKT cells in host defense as well as tumor clearance, and B cell differentiation and their mechanisms in terms of antigen presentation and immune response to vaccination and tumors.

Intrigued by the innovative and translational research and development that are in many areas related to her own interests of tumor immunology with creative problem solving, Dr. Chen joined BioMagnetic Solutions and works closely with Dr. Liberti to apply the company’s magnetic nanoparticle technology to create tools for immune cell therapy.

Dr. Chen leads the research and development team, oversees product development and manufacture for highly sophisticated cell separations.